From: High expression of HLA-E in colorectal carcinoma is associated with a favorable prognosis
 | DISEASE-FREE SURVIVAL | |||
---|---|---|---|---|
 | Univariate Analysis | Multivariate Analysis | ||
Prognostic factors | HR 1 (95% CI) 2 | p value | HR (95% CI) | p value |
Stage III vs II | 2.55 (1.41-4.60) | 0.002 | 2.77 (1.45-5.28) | 0.002 |
HCA2 relative score (+3/+2/-3/-2 vs others) | 2.50 (0.18-5.31) | 0.02 | 2.94 (1.36-6.34) | 0.006 |
MEM-E/02 absolute score (0/1/2 vs 3) | 1.90 (1.05-3.45) | 0.03 | 1.82 (0.96-3.45) | 0.06 |
T (3/4 vs 1/2) | 1.26 (0.56-2.82) | 0.58 | Â | Â |
Grading (2/3 vs 1) | 1.95 (0.47-8.04) | 0.36 | Â | Â |
HCA2 absolute score (0/1 vs 2/3) | 1.47 (0.77-2.79) | 0.25 | Â | Â |
HC10 absolute score (2/3 vs 0/1) | 2.40 (0.74-7.74) | 0.14 | Â | Â |
L31 absolute score (0/1 vs 2/3) | 1.36 (0.73-2. 57) | 0.33 | Â | Â |
 | OVERALL SURVIVAL | |||
 | Univariate Analysis | Multivariate Analysis | ||
Prognostic factors | HR 1 (95% CI) 2 | p value | HR (95% CI) | p value |
Stage III vs II | 2.78 (1.45-5.34) | 0.002 | 2.49 (1.23-5.04) | 0.01 |
HCA2 relative score (+3/+2/-3/-2 vs others) | 3.09 (1.43-6.69) | 0.004 | 3.55 (1.61-7.87) | 0.002 |
MEM-E/02 absolute score (0/1/2 vs 3) | 1.96 (1.01-3.81) | 0.05 | 1.81 (0.90-3.63) | 0.09 |
T (3/4 vs 1/2) | 1.41 (0.55-3.61) | 0.48 | Â | Â |
Grading (2/3 vs 1) | 1.57 (0.38-6.52) | 0.54 | Â | Â |
HCA2 absolute score (0/1 vs 2/3) | 1.66 (0.83-3.31) | 0.15 | Â | Â |
HC10 absolute score (2/3 vs 0/1) | 1.91 (0.59-6.22) | 0.28 | Â | Â |
L31 absolute score (0/1 vs 2/3) | 1.21 (0.60-2.44) | 0.61 | Â | Â |